Although very much disagreeing with biohacking practices, and strongly discouraging them, the FDA has never actually intervened themselves with individuals. Should they?
Altering the genome, typically to better understand gene and protein function. This also paves the way for gene therapy.
The European Patent Office (EPO) has revoked a patent granted to the Broad Institute for fundamental aspects of the technology, in the latest installment of the CRISPR patent battle.
With the possibility that CRISPR-Cas9 could prove ineffective in humans, there was talk that the stocks of these biotechs could turn out to be worthless. But the cart got before the horse — by a few miles.
The U.S. are the closest they’ve ever been to using gene-editing tool, CRISPR for the first time in a human test in a bid to tackle deadly cancers.
This year we can expect to see large numbers of CRISPR gene-editing trials, but some are still afraid of this amazing technology.
At ASHG, we spoke to Gavin Stone, Vice President of Marketing at Edico Genome, to discuss their World Record achievement in more detail, as well as the advantages offered by their DRAGEN tool.
Microsoft thinks that artificial intelligence might be one way to fine-tune CRISPR, and resolve what scientists have been working on for a long while.
A new study shows that a repair mechanism meant to repair DNA sequences after mutations prefers to repair genes instead of other areas of the genome. The research could lead to insight into human diseases.
All on its own, the presence of SRY can make a female turn out to be essentially male—with bigger muscles, a penis, and testicles (although unable to make sperm).
Researchers hope to use genetic information found in female mosquitoes to stop mosquitoes from feeding on blood, which would, in turn, stop the spread of many serious diseases.
Eating Less Chocolate in 2018? You Might Want to Reconsider as Your Favourite Treat Could Be Extinct by 2050
If your New Year’s Resolution was to give up chocolate, you might find it easier to do it in 2050, when scientists suspect chocolate may go extinct.
Unless, that is, gene-editing scientists manage to save it.
Sinogene, a biotech company based in Beijing has cloned a gene-edited dog in an attempt to treat cardiovascular disease.